# PRISM Table of Contents

*This document provides a comprehensive, hierarchical table of contents for all PRISM documentation with direct links to specific sections.*

## Navigation Hub

This page serves as the primary navigation hub for the PRISM documentation collection, providing direct links to all documents and their major sections.


## Introduction & Overview

### [PRISM Initiative Contact & Resources](/00-contact-and-project-information)
- [Project Resources](/00-contact-and-project-information#project-resources)
  - [Code & Models](/00-contact-and-project-information#code-models)
  - [Contact](/00-contact-and-project-information#contact)
- [Founding Team](/00-contact-and-project-information#founding-team)
  - [Brian Jorden](/00-contact-and-project-information#brian-jorden)
  - [Timothy Collins](/00-contact-and-project-information#timothy-collins)
  - [Ryan Herchig](/00-contact-and-project-information#ryan-herchig)
- [Getting Involved](/00-contact-and-project-information#getting-involved)
- [Open Collaboration](/00-contact-and-project-information#open-collaboration)
- [Public Benefit Mission](/00-contact-and-project-information#public-benefit-mission)

### [PRISM Initiative: Executive Summary](/01-executive-summary)
- [The Problem](/01-executive-summary#the-problem)
- [The Solution](/01-executive-summary#the-solution)
- [Core Innovation](/01-executive-summary#core-innovation)
- [Business Model Alignment](/01-executive-summary#business-model-alignment)
- [Implementation Strategy](/01-executive-summary#implementation-strategy)
- [Safeguards and Ethics](/01-executive-summary#safeguards-and-ethics)
- [Evidence Base](/01-executive-summary#evidence-base)
- [Collaborative Framework](/01-executive-summary#collaborative-framework)
- [Team and Organization](/01-executive-summary#team-and-organization)
- [Future Vision](/01-executive-summary#future-vision)
- [Investment Opportunity](/01-executive-summary#investment-opportunity)

### [PRISM Document Summaries](/02-document-summaries)
- [Purpose](/02-document-summaries#purpose)
- [Structure](/02-document-summaries#structure)


## Foundation & Data Architecture

### [PRISM Data Format](/10-prism-data-format)
- [Introduction to Structured Medical Narratives](/10-prism-data-format#introduction-to-structured-medical-narratives)
- [The Eight-Field Structure](/10-prism-data-format#the-eight-field-structure)
  - [POOL: Training Group Assignment](/10-prism-data-format#pool-training-group-assignment)
  - [PATIENT: Cryptographic Identifier](/10-prism-data-format#patient-cryptographic-identifier)
  - [ASL: Age/Sex/Location Demographics](/10-prism-data-format#asl-agesexlocation-demographics)
  - [WHO: Provider Taxonomy](/10-prism-data-format#who-provider-taxonomy)
  - [WHAT: Procedures and Products](/10-prism-data-format#what-procedures-and-products)
  - [WHEN: Temporal Anchoring](/10-prism-data-format#when-temporal-anchoring)
  - [WHERE: Service Location](/10-prism-data-format#where-service-location)
  - [WHY: Diagnostic Context](/10-prism-data-format#why-diagnostic-context)
- [Temporal Progression and Age Changes](/10-prism-data-format#temporal-progression-and-age-changes)
- [Why Markdown Tables](/10-prism-data-format#why-markdown-tables)
- [Relationship to Sequence Completion](/10-prism-data-format#relationship-to-sequence-completion)
- [Data Volume Implications](/10-prism-data-format#data-volume-implications)

### [Completely Anonymous Data Only](/11-completely-anonymous-data)
- [Defining Complete Anonymity vs De-identification](/11-completely-anonymous-data#defining-complete-anonymity-vs-de-identification)
- [MD5 Hashing for Verification](/11-completely-anonymous-data#md5-hashing-for-verification)
- [Why Anonymity Enables Pattern Recognition](/11-completely-anonymous-data#why-anonymity-enables-pattern-recognition)
- [Computational Efficiency Benefits](/11-completely-anonymous-data#computational-efficiency-benefits)
- [Privacy as Foundational Architecture](/11-completely-anonymous-data#privacy-as-foundational-architecture)
- [Legal and Ethical Advantages](/11-completely-anonymous-data#legal-and-ethical-advantages)
- [What PRISM Never Knows](/11-completely-anonymous-data#what-prism-never-knows)

### [Insurance Company Unique Vantage Point](/12-insurance-vantage-point)
- [Cross-Provider Visibility](/12-insurance-vantage-point#cross-provider-visibility)
- [Longitudinal Patient Journeys](/12-insurance-vantage-point#longitudinal-patient-journeys)
- [Fragmentation in Healthcare Delivery](/12-insurance-vantage-point#fragmentation-in-healthcare-delivery)
- [What Individual Providers Cannot See](/12-insurance-vantage-point#what-individual-providers-cannot-see)
- [Claims Data Completeness](/12-insurance-vantage-point#claims-data-completeness)
- [Why Not Hospitals or Health Systems](/12-insurance-vantage-point#why-not-hospitals-or-health-systems)
- [Existing Infrastructure Advantages](/12-insurance-vantage-point#existing-infrastructure-advantages)

### [Standardized and Finite Codesets](/13-standardized-codesets)
- [Universal Medical Languages](/13-standardized-codesets#universal-medical-languages)
  - [ICD-10-CM for Diagnoses](/13-standardized-codesets#icd-10-cm-for-diagnoses)
  - [CPT for Procedures](/13-standardized-codesets#cpt-for-procedures)
  - [ICD-10-PCS for Hospital Procedures](/13-standardized-codesets#icd-10-pcs-for-hospital-procedures)
  - [HCPCS for Supplies and Services](/13-standardized-codesets#hcpcs-for-supplies-and-services)
  - [NDC for Medications](/13-standardized-codesets#ndc-for-medications)
  - [CMS Place of Service Codes](/13-standardized-codesets#cms-place-of-service-codes)
  - [NUCC Provider Taxonomy](/13-standardized-codesets#nucc-provider-taxonomy)
- [Finite and Documented Nature](/13-standardized-codesets#finite-and-documented-nature)
- [LLM Pre-training Advantages](/13-standardized-codesets#llm-pre-training-advantages)
- [Code Evolution and Version Management](/13-standardized-codesets#code-evolution-and-version-management)

### [Three-Pattern Learning](/14-three-pattern-learning)
- [Defining GOOD Examples](/14-three-pattern-learning#defining-good-examples)
- [Defining BAD Examples](/14-three-pattern-learning#defining-bad-examples)
- [Defining NOPE Examples](/14-three-pattern-learning#defining-nope-examples)
- [Automated Pattern Extraction](/14-three-pattern-learning#automated-pattern-extraction)
- [Primary Aldosteronism as Demonstration](/14-three-pattern-learning#primary-aldosteronism-as-demonstration)
- [Generalizing to Other Conditions](/14-three-pattern-learning#generalizing-to-other-conditions)
- [Training Data Balance](/14-three-pattern-learning#training-data-balance)


## AI Architecture & Philosophy

### [Pure Sequence Completion Without Complexity](/20-pure-sequence-completion)
- [Supervised Fine-Tuning as Continued Pre-Training](/20-pure-sequence-completion#supervised-fine-tuning-as-continued-pre-training)
  - [The Foundation Learning Process](/20-pure-sequence-completion#the-foundation-learning-process)
  - [What Models Learn During SFT](/20-pure-sequence-completion#what-models-learn-during-sft)
  - [The Transition to Specialized Models](/20-pure-sequence-completion#the-transition-to-specialized-models)
- [Destroying General Capabilities Intentionally](/20-pure-sequence-completion#destroying-general-capabilities-intentionally)
- [No Chat, No Reasoning, Just Continuation](/20-pure-sequence-completion#no-chat-no-reasoning-just-continuation)
- [Training to Exhaustion on Medical Sequences](/20-pure-sequence-completion#training-to-exhaustion-on-medical-sequences)
- [Condition-Specific Nudges Through BCO](/20-pure-sequence-completion#condition-specific-nudges-through-bco)
- [Why Simplicity Works](/20-pure-sequence-completion#why-simplicity-works)
- [Avoiding Modern AI Complexity](/20-pure-sequence-completion#avoiding-modern-ai-complexity)

### [Ensemble of 100 Specialized Models](/21-ensemble-models)
- [Data Segmentation Strategy](/21-ensemble-models#data-segmentation-strategy)
- [Pool Assignment Methodology (Last Two Digits)](/21-ensemble-models#pool-assignment-methodology-last-two-digits)
- [Complete Independence Between Models](/21-ensemble-models#complete-independence-between-models)
- [Natural Cross-Validation](/21-ensemble-models#natural-cross-validation)
- [Why Exactly 100](/21-ensemble-models#why-exactly-100)
- [Consensus as Evidence](/21-ensemble-models#consensus-as-evidence)
- [Model Diversity Benefits](/21-ensemble-models#model-diversity-benefits)

### [Retrospective-Prospective Validation](/22-retrospective-prospective)
- [Truncation Methodology](/22-retrospective-prospective#truncation-methodology)
- [Historical Validation Process](/22-retrospective-prospective#historical-validation-process)
- [Empirical Performance Metrics](/22-retrospective-prospective#empirical-performance-metrics)
- [Known Outcome Advantages](/22-retrospective-prospective#known-outcome-advantages)
- [Continuous Validation Approach](/22-retrospective-prospective#continuous-validation-approach)
- [Building Confidence Through History](/22-retrospective-prospective#building-confidence-through-history)

### ["All Models are Wrong" Philosophy](/23-all-models-wrong)
- [Embracing Useful Wrongness](/23-all-models-wrong#embracing-useful-wrongness)
- [Medical Investigation Reality](/23-all-models-wrong#medical-investigation-reality)
- [Value of Rare Catches](/23-all-models-wrong#value-of-rare-catches)
- [Alignment with Clinical Practice](/23-all-models-wrong#alignment-with-clinical-practice)
- [Statistical Framework](/23-all-models-wrong#statistical-framework)

### [Constructive-Only Architecture](/24-constructive-only)
- [Architectural Prevention of Denial](/24-constructive-only#architectural-prevention-of-denial)
- [Counting Positive Suggestions Only](/24-constructive-only#counting-positive-suggestions-only)
- [Silence When No Consensus](/24-constructive-only#silence-when-no-consensus)
- [Structural Safeguards](/24-constructive-only#structural-safeguards)
- [Ethical Implications](/24-constructive-only#ethical-implications)
- [Business Model Alignment](/24-constructive-only#business-model-alignment)


## Examples & Demonstrations

### [PRISM: Synthetic Case Examples and Training Framework](/30-synthetic-cases)
- [Understanding the Visual Framework](/30-synthetic-cases#understanding-the-visual-framework)
  - [Core Training Elements](/30-synthetic-cases#core-training-elements)
  - [Demonstration Elements](/30-synthetic-cases#demonstration-elements)
- [The Training Framework](/30-synthetic-cases#the-training-framework)
- [Important Clarifications](/30-synthetic-cases#important-clarifications)
  - [SIGN Markers Are Demonstration Only](/30-synthetic-cases#sign-markers-are-demonstration-only)
  - [Code Identification and Adapter Creation](/30-synthetic-cases#code-identification-and-adapter-creation)
  - [Replicable Framework for Multiple Conditions](/30-synthetic-cases#replicable-framework-for-multiple-conditions)
  - [Training Implementation Notes](/30-synthetic-cases#training-implementation-notes)
  - [Processing Optimization](/30-synthetic-cases#processing-optimization)
- [What You'll See in the Examples](/30-synthetic-cases#what-youll-see-in-the-examples)

### [PRISM GOOD Example: Early Detection of Primary Aldosteronism](/31-good-example)
- [Clinical Narrative](/31-good-example#clinical-narrative)
- [Five Ws Data Sequence](/31-good-example#five-ws-data-sequence)
- [Key Pattern Recognition Elements](/31-good-example#key-pattern-recognition-elements)

### [PRISM BAD Example: Delayed Diagnosis of Primary Aldosteronism](/32-bad-example)
- [Clinical Narrative](/32-bad-example#clinical-narrative)
- [Five Ws Data Sequence](/32-bad-example#five-ws-data-sequence)
- [Key Pattern Recognition Elements](/32-bad-example#key-pattern-recognition-elements)

### [PRISM NOPE Example: Sleep Apnea Presenting as Resistant Hypertension](/33-nope-example)
- [Clinical Narrative](/33-nope-example#clinical-narrative)
- [Five Ws Data Sequence](/33-nope-example#five-ws-data-sequence)
- [Key Pattern Recognition Elements](/33-nope-example#key-pattern-recognition-elements)

### [Sequence Generation Demonstration](/34-generation-demonstration)

### [Audio & Video Resources](/35-audio-video-resources)


## Implementation & Operations

### [Consensus Voting Mechanism](/40-consensus-voting)
- [Threshold Calibration Process](/40-consensus-voting#threshold-calibration-process)
- [Condition-Specific Requirements](/40-consensus-voting#condition-specific-requirements)
- [Medical Oversight Integration](/40-consensus-voting#medical-oversight-integration)
- [Balancing Sensitivity and Specificity](/40-consensus-voting#balancing-sensitivity-and-specificity)
- [Dynamic Adjustment Capability](/40-consensus-voting#dynamic-adjustment-capability)

### [Clinical Decision Support Positioning](/41-clinical-decision-support)
- [FDA Regulatory Framework](/41-clinical-decision-support#fda-regulatory-framework)
- [Physician Autonomy Preservation](/41-clinical-decision-support#physician-autonomy-preservation)
- [Physician-Friendly Explanation Generation](/41-clinical-decision-support#physician-friendly-explanation-generation)
  - [The Explanation Generation Architecture](/41-clinical-decision-support#the-explanation-generation-architecture)
  - [Crafting Clinically Relevant Narratives](/41-clinical-decision-support#crafting-clinically-relevant-narratives)
  - [Integration with Clinical Workflow](/41-clinical-decision-support#integration-with-clinical-workflow)
- [Human-in-the-Loop Requirements](/41-clinical-decision-support#human-in-the-loop-requirements)
- [Communication to PCPs Only](/41-clinical-decision-support#communication-to-pcps-only)
- [Liability Considerations](/41-clinical-decision-support#liability-considerations)
- [Integration with Clinical Workflows](/41-clinical-decision-support#integration-with-clinical-workflows)

### [Self-Aligning Incentive Structure](/42-incentive-structure)
- [Results-Based Compensation Model](/42-incentive-structure#results-based-compensation-model)
- [Pre-Agreed Percentage of Savings](/42-incentive-structure#pre-agreed-percentage-of-savings)
- [PRISM-Specific ICD Tracking Codes](/42-incentive-structure#prism-specific-icd-tracking-codes)
- [Patient Cost Coverage Goals](/42-incentive-structure#patient-cost-coverage-goals)
- [Why Not Fee-for-Service](/42-incentive-structure#why-not-fee-for-service)
- [Long-term Sustainability](/42-incentive-structure#long-term-sustainability)

### [Platform Potential with Constraints](/43-platform-potential)
- [Focus on Non-Invasive Tests](/43-platform-potential#focus-on-non-invasive-tests)
- [Routine Visit Integration](/43-platform-potential#routine-visit-integration)
- [Condition Selection Criteria](/43-platform-potential#condition-selection-criteria)
- [Rapid Expansion Capability](/43-platform-potential#rapid-expansion-capability)
- [What PRISM Won't Target](/43-platform-potential#what-prism-wont-target)

### [Healthcare Utilization Phenotype Recognition](/44-phenotype-recognition)
- [Defining Utilization Phenotypes](/44-phenotype-recognition#defining-utilization-phenotypes)
- [How Conditions Express in Billing Data](/44-phenotype-recognition#how-conditions-express-in-billing-data)
- [Temporal Evolution of Patterns](/44-phenotype-recognition#temporal-evolution-of-patterns)
- [Multi-Provider Manifestations](/44-phenotype-recognition#multi-provider-manifestations)
- [Observable vs Clinical Phenotypes](/44-phenotype-recognition#observable-vs-clinical-phenotypes)
- [Research Implications](/44-phenotype-recognition#research-implications)

### [Zero Integration Burden](/45-zero-integration)
- [Using Existing Data Flows](/45-zero-integration#using-existing-data-flows)
- [No Workflow Changes Required](/45-zero-integration#no-workflow-changes-required)
- [Existing Communication Channels](/45-zero-integration#existing-communication-channels)
- [On-Premises Hardware Management](/45-zero-integration#on-premises-hardware-management)
- [Remote Administration Model](/45-zero-integration#remote-administration-model)
- [True Background Operation](/45-zero-integration#true-background-operation)


## Infrastructure & Processing

### [Cluster Architecture Approach](/50-cluster-architecture)
- [Server Rack Design](/50-cluster-architecture#server-rack-design)
- [Consumer GPU Strategy](/50-cluster-architecture#consumer-gpu-strategy)
- [Modular Enclosures](/50-cluster-architecture#modular-enclosures)
- [Network Isolation](/50-cluster-architecture#network-isolation)
- [Graceful Degradation](/50-cluster-architecture#graceful-degradation)
- [Linear Scaling Properties](/50-cluster-architecture#linear-scaling-properties)

### [Continuous Model Retraining](/51-continuous-retraining)
- [One Model Per Day Target](/51-continuous-retraining#one-model-per-day-target)
- [100-Day Complete Cycle](/51-continuous-retraining#100-day-complete-cycle)
- [Data Freshness Strategy](/51-continuous-retraining#data-freshness-strategy)
- [Model Replacement Process](/51-continuous-retraining#model-replacement-process)
- [Feedback Incorporation](/51-continuous-retraining#feedback-incorporation)
- [Quality Assurance Testing](/51-continuous-retraining#quality-assurance-testing)

### [Continuous Batch Inference Process](/52-batch-inference)
- [Background Processing Design](/52-batch-inference#background-processing-design)
- [Patient Prioritization Logic](/52-batch-inference#patient-prioritization-logic)
- [No Physician Initiation Required](/52-batch-inference#no-physician-initiation-required)
- [Computational Efficiency](/52-batch-inference#computational-efficiency)


## Collaboration & Growth

### [Open Collaboration with Privacy Protection](/60-open-collaboration)
- [Model Sharing Without Data Sharing](/60-open-collaboration#model-sharing-without-data-sharing)
- [Collective Intelligence Benefits](/60-open-collaboration#collective-intelligence-benefits)
- [Model Merging Process](/60-open-collaboration#model-merging-process)
- [Secure Contribution Framework](/60-open-collaboration#secure-contribution-framework)
- [Early Adopter Advantages](/60-open-collaboration#early-adopter-advantages)
- [Dual Contribution Model](/60-open-collaboration#dual-contribution-model)
  - [Trained Model Contributions](/60-open-collaboration#trained-model-contributions)
  - [Technical Improvement Contributions](/60-open-collaboration#technical-improvement-contributions)
- [Code Transparency with Protected Models](/60-open-collaboration#code-transparency-with-protected-models)
  - [What's Completely Open](/60-open-collaboration#whats-completely-open)
  - [What Requires Licensing](/60-open-collaboration#what-requires-licensing)
  - [Removing Barriers While Maintaining Incentives](/60-open-collaboration#removing-barriers-while-maintaining-incentives)
- [Exponential Early Adopter Benefits](/60-open-collaboration#exponential-early-adopter-benefits)
  - [The Compounding Value of Network Growth](/60-open-collaboration#the-compounding-value-of-network-growth)
  - [Beyond Linear Scaling](/60-open-collaboration#beyond-linear-scaling)
  - [Strategic Advantage Through Early Participation](/60-open-collaboration#strategic-advantage-through-early-participation)
- [Implementation Agreement Framework](/60-open-collaboration#implementation-agreement-framework)
  - [Operational Requirements](/60-open-collaboration#operational-requirements)
  - [Technical Contribution Requirements](/60-open-collaboration#technical-contribution-requirements)
  - [Ethical Commitments](/60-open-collaboration#ethical-commitments)
- [Competitive Dynamics and Rational Collaboration](/60-open-collaboration#competitive-dynamics-and-rational-collaboration)
  - [Why Traditional Competition Fails Here](/60-open-collaboration#why-traditional-competition-fails-here)
  - [The Collaboration Advantage](/60-open-collaboration#the-collaboration-advantage)
  - [Transforming Competition](/60-open-collaboration#transforming-competition)
- [Network Effects](/60-open-collaboration#network-effects)


## Organization & Research

### [Large and Rich Dataset](/70-large-dataset)
- [Token Scale Calculations](/70-large-dataset#token-scale-calculations)
- [Maximizing Temporal Context](/70-large-dataset#maximizing-temporal-context)
- [Rare Pattern Detection](/70-large-dataset#rare-pattern-detection)
- [Gradual Progression Capture](/70-large-dataset#gradual-progression-capture)
- [Statistical Power Benefits](/70-large-dataset#statistical-power-benefits)
- [Data Density Around Medical Events](/70-large-dataset#data-density-around-medical-events)
- [Semantic Richness of Medical Codes](/70-large-dataset#semantic-richness-of-medical-codes)

### [PBC Structure and Team](/71-pbc-team)
- [Public Benefit Corporation Rationale](/71-pbc-team#public-benefit-corporation-rationale)
- [Patient Outcome Priority](/71-pbc-team#patient-outcome-priority)
- [Investment Framework Compatibility](/71-pbc-team#investment-framework-compatibility)
- [Founding Team Expertise](/71-pbc-team#founding-team-expertise)
- [Advisory Relationships](/71-pbc-team#advisory-relationships)
- [Growth Strategy](/71-pbc-team#growth-strategy)

### [Research and Publication](/72-research-publication)
- [Peer Review Commitment](/72-research-publication#peer-review-commitment)
- [Pattern Discovery Potential](/72-research-publication#pattern-discovery-potential)
- [Academic Credibility Building](/72-research-publication#academic-credibility-building)
- [Open Research Philosophy](/72-research-publication#open-research-philosophy)
- [Contribution to Medical Knowledge](/72-research-publication#contribution-to-medical-knowledge)
- [Collaborative Opportunities](/72-research-publication#collaborative-opportunities)


## Technical Deep Dives

### [Vector Representations & Mathematical Foundations](/85-vector-representations)
- [Transforming Medical Sequences into Mathematical Space](/85-vector-representations#transforming-medical-sequences-into-mathematical-space)
- [The Geometry of Medical Similarity](/85-vector-representations#the-geometry-of-medical-similarity)
- [Trajectory Analysis Through Time](/85-vector-representations#trajectory-analysis-through-time)
- [Mathematical Similarity for Patient Prioritization](/85-vector-representations#mathematical-similarity-for-patient-prioritization)
- [Embedding Space Properties](/85-vector-representations#embedding-space-properties)
- [Dimensionality and Information Density](/85-vector-representations#dimensionality-and-information-density)
- [Practical Implications for Pattern Recognition](/85-vector-representations#practical-implications-for-pattern-recognition)

### [Technology Stack & Core Libraries](/86-technology-stack)

### [Processing Pipeline Specifications](/87-processing-pipeline)
- [Stage 1: Patient Selection and Prioritization](/87-processing-pipeline#stage-1-patient-selection-and-prioritization)
- [Stage 2: Parallel Model Inference](/87-processing-pipeline#stage-2-parallel-model-inference)
- [Stage 3: Consensus Aggregation](/87-processing-pipeline#stage-3-consensus-aggregation)
- [Stage 4: Explanation Generation](/87-processing-pipeline#stage-4-explanation-generation)
- [Stage 5: Delivery to Insurance Company](/87-processing-pipeline#stage-5-delivery-to-insurance-company)

### [Reference Architecture & Implementation Standards](/88-reference-architecture)


## References & Resources

### [Glossary of Terms](/99-glossary-of-terms)

